See the DrugPatentWatch profile for Glimepiride
Glimepiride is a generic medication manufactured by various pharmaceutical companies. It is a sulfonylurea drug used to treat type 2 diabetes by helping the body produce more insulin and decreasing the amount of sugar released by the liver.
Who makes brand-name Glimepiride?
The original brand-name version of glimepiride was Amaryl, manufactured by Sanofi-Aventis [1].
What companies produce generic Glimepiride?
Following the expiration of patents, numerous pharmaceutical companies have begun manufacturing and distributing generic versions of glimepiride. These include, but are not limited to, Teva Pharmaceuticals, Mylan (now Viatris), Sun Pharmaceutical Industries, Aurobindo Pharma, and Cipla [2]. The availability of generic glimepiride has contributed to increased accessibility and affordability for patients.
When did Glimepiride patents expire?
Patent expirations for branded medications like Amaryl allow for the introduction of generic versions. Specific patent expiration dates can vary by country and may be subject to legal challenges. Information on patent status and expiry for pharmaceutical products can be found through resources like DrugPatentWatch.com [3].
How does Glimepiride work?
Glimepiride belongs to the sulfonylurea class of oral diabetes medications. It stimulates the pancreas to release more insulin and also reduces the amount of glucose produced by the liver. This dual action helps to lower blood sugar levels in individuals with type 2 diabetes [4].